Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.45 |
| ▸ | RAB9A | P51151 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.45 |
| ▸ | RELA | Q04206 | 1/20 | 0.45 |
| ▸ | FFAR4 | Q5NUL3 | 7/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.43 |
| ▸ | PPARD | Q03181 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17865394 | 0.82 | HPGD (0.48) | HPGDNPSR1NPC1RAB9AMEN1 | |
| SCHEMBL17865383 | 0.78 | CYP2C9 (0.46) | HPGDNPSR1MEN1KMT2AMAPT | |
| SCHEMBL17865382 | 0.77 | KMT2A (0.51) | HPGDNPSR1NPC1RAB9AMEN1 | |
| SCHEMBL17865384 | 0.76 | ROCK2 (0.49) | HPGDNPSR1MEN1KMT2A | |
| SCHEMBL17865381 | 0.76 | HPGD (0.57) | HPGDNPSR1PPARGPPARA | |
| SCHEMBL17865392 | 0.75 | HPGD (0.52) | HPGDNPSR1NPC1RAB9AMEN1 | |
| SCHEMBL17865388 | 0.75 | NPSR1 (0.48) | HPGDNPSR1NPC1RAB9AMEN1 | |
| SCHEMBL17865398 | 0.71 | ACACB (0.47) | HPGDNPSR1MEN1KMT2AFFAR1 | |
| SCHEMBL18082335 | 0.71 | NPC1 (0.71) | HPGDNPSR1NPC1RAB9AKMT2A | |
| SCHEMBL8738314 | 0.70 | HPGD (0.66) | HPGDNPSR1KMT2AMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10299475-B2 | Pesticide | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2019-05-28 | — | — | US | disclosed |
| US-20160192651-A1 | PESTICIDE | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| EP-3037408-A1 | HARMFUL ORGANISM CONTROL AGENT | Ishihara Sangyo Kaisha, Ltd. (JP) | 2016-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10299475-B2 | Pesticide | DDT, ACHE, KCNH1 | HPGD 4335/4885NPSR1 1003/4885NPC1 3719/4885 |
| US-20160192651-A1 | PESTICIDE | DDT, ACHE, KCNH1 | HPGD 4335/4885NPSR1 1003/4885NPC1 3719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.